Cargando…

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness

In order to support vaccine development, and to aid convalescent plasma therapy, it would be important to understand the kinetics, timing and persistence of SARS-CoV-2 neutralizing antibodies (NAbs), and their association with clinical disease severity. Therefore, we used a surrogate viral neutraliz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeewandara, Chandima, Jayathilaka, Deshni, Gomes, Laksiri, Wijewickrama, Ananda, Narangoda, Eranga, Idampitiya, Damayanthi, Guruge, Dinuka, Wijayamuni, Ruwan, Manilgama, Suranga, Ogg, Graham S., Tan, Chee Wah, Wang, Lin-Fa, Malavige, Gathsaurie Neelika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819970/ https://www.ncbi.nlm.nih.gov/pubmed/33479465 http://dx.doi.org/10.1038/s41598-021-81629-2

Ejemplares similares

Similarities and differences between the ‘cytokine storms’ in acute dengue and COVID-19
por: Dayarathna, Shashika, et al.
Publicado: (2020)

Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS‑CoV‑2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients
por: Kamaladasa, Achala, et al.
Publicado: (2021)

Comparison of different sequencing techniques for identification of SARS-CoV-2 variants of concern with multiplex real-time PCR
por: Ranasinghe, Diyanath, et al.
Publicado: (2022)

Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222
por: Jayathilaka, Deshni, et al.
Publicado: (2022)

Phenotype and functionality of follicular helper T cells in patients with acute dengue infection
por: Wijesinghe, Ayesha, et al.
Publicado: (2020)

Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection
por: Jayathilaka, Deshni, et al.
Publicado: (2018)

Molecular Epidemiology of AY.28 and AY.104 Delta Sub-lineages in Sri Lanka
por: Ranasinghe, Diyanath, et al.
Publicado: (2022)

Efficacy of rupatadine in reducing the incidence of dengue haemorrhagic fever in patients with acute dengue: A randomised, double blind, placebo-controlled trial
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2022)

Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection
por: Jeewandara, Chandima, et al.
Publicado: (2022)

Urinary leukotrienes and histamine in patients with varying severity of acute dengue
por: Silva, Tehani, et al.
Publicado: (2021)

Transmission dynamics, clinical characteristics and sero-surveillance in the COVID-19 outbreak in a population dense area of Colombo, Sri Lanka April- May 2020
por: Jeewandara, Chandima, et al.
Publicado: (2021)

Development and validation of an assay for detection of Japanese encephalitis virus specific antibody responses
por: Pushpakumara, Pradeep Darshana, et al.
Publicado: (2020)

Genomic and Epidemiological Analysis of SARS-CoV-2 Viruses in Sri Lanka
por: Jeewandara, Chandima, et al.
Publicado: (2021)

Quantification of dengue virus specific T cell responses and correlation with viral load and clinical disease severity in acute dengue infection
por: Wijeratne, Dulharie T., et al.
Publicado: (2018)

Patterns and causes of liver involvement in acute dengue infection
por: Fernando, Samitha, et al.
Publicado: (2016)

Dysfunctional Innate Immune Responses and Severe Dengue
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2020)

Dengue and COVID-19: two sides of the same coin
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2022)

Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka
por: Jeewandara, Chandima, et al.
Publicado: (2022)

Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2021)

Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2022)

A preliminary study on efficacy of rupatadine for the treatment of acute dengue infection
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2018)

Adipokine levels and their association with clinical disease severity in patients with dengue
por: Kuruppu, Heshan, et al.
Publicado: (2023)

Adipokine levels and their association with clinical disease severity in patients with dengue
por: Kuruppu, Heshan, et al.
Publicado: (2023)

Dengue NS1 antigen as a marker of severe clinical disease
por: Paranavitane, Shiran Ajith, et al.
Publicado: (2014)

Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes
por: Pushpakumara, Pradeep Darshana, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka
por: Jeewandara, Chandima, et al.
Publicado: (2021)

Association of dengue virus‐specific polyfunctional T‐cell responses with clinical disease severity in acute dengue infection
por: Wijeratne, Dulharie T., et al.
Publicado: (2019)

Risk Factors for Elevated Serum Lipopolysaccharide in Acute Dengue and Association with Clinical Disease Severity
por: Shyamali, N. L. Ajantha, et al.
Publicado: (2020)

Secretory phospholipase A2 in the pathogenesis of acute dengue infection
por: Jeewandara, Chandima, et al.
Publicado: (2016)

Epidemiological and virological factors determining dengue transmission in Sri Lanka during the COVID-19 pandemic
por: Ariyaratne, Dinuka, et al.
Publicado: (2022)

Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka
por: Jeewandara, Chandima, et al.
Publicado: (2022)

Suppression of Virus Specific Immune Responses by IL-10 in Acute Dengue Infection
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2013)

Surveillance of SARS-CoV-2 variants of concern by identification of single nucleotide polymorphisms in the spike protein by a multiplex real-time PCR
por: Gomes, Laksiri, et al.
Publicado: (2022)

Functionality of Dengue Virus Specific Memory T Cell Responses in Individuals Who Were Hospitalized or Who Had Mild or Subclinical Dengue Infection
por: Jeewandara, Chandima, et al.
Publicado: (2015)

Identification of Novel Candidate CD8(+) T Cell Epitopes of the SARS-CoV2 with Homology to Other Seasonal Coronaviruses
por: Pushpakumara, Pradeep Darshana, et al.
Publicado: (2021)

Platelet Activating Factor Contributes to Vascular Leak in Acute Dengue Infection
por: Jeewandara, Chandima, et al.
Publicado: (2015)

Sphingosine 1-Phosphate in Acute Dengue Infection
por: Gomes, Laksiri, et al.
Publicado: (2014)

Changing epidemiology of dengue in Sri Lanka—Challenges for the future
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2021)

Change in Dengue and Japanese Encephalitis Seroprevalence Rates in Sri Lanka
por: Jeewandara, Chandima, et al.
Publicado: (2015)

Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sraper0u9grl6uq31vhskod8uo